Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units

Anti-Cancer Drugs

Volumn 9, Issue 4, 1998, Pages 327-331

  Soda, Hiroshi ^a   Raymond, Eric ^a   Sharma, Sunil ^a   Lawrence, Richard ^a   Cerna, Cesario ^a   Gomez, Lionel ^a   Timony, Gregg A ^b   Von Hoff, Daniel D ^a   Izbicka, Elzbieta ^a  

^a CTRC Institute for Drug Development   (United States)

^b PFIZER INC   (United States)

Author keywords

Antineoplastic agents; Growth factors; Human tumor cloning assay

Indexed keywords

BONE MORPHOGENETIC PROTEIN; RECOMBINANT PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER SURVIVAL; COLONY FORMING UNIT; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR CLONING; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0031778161     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199804000-00006     Document Type: Article

References (29)

1. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR. Bone morphogenetic protein-2. Clin Orthoped Rel Res 1996; 324: 39-46.
2. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893-9.
3. Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor β family members presents in bone-inductive protein purified bovine bone. Proc Natl Acad Sci USA 1990; 87: 9843-7.
4. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-34.
5. Thies RS, Bauduy M, Ashton BA, et al. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992; 130: 1318-24.
6. Yamaguchi A, Katagiri T, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991; 113: 681-7.
7. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC2T3-E1. Biochem Biophys Res Commun 1991; 174: 96-101.
8. Katagiri T, Yamaguchi A, Ikeda T, et al. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990; 172: 295-9.
9. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990; 87: 2220-4.
10. Lyons KM, Pelton RW, Hogan BLM. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein 2A (BMP-2A). Development 1990; 109: 833-84.
11. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-46.
12. Massague J. TGF β signaling: receptors, transducers, and Mad proteins. Cell 1996; 85: 947-50.
13. Norgaard P, Hougaard S, Poulsen HS, Spang-Thomsen M. Transforming growth factor β and cancer. Cancer Treat Rev 1995; 21: 367-403.
14. 1 induced apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 1992; 52: 4042-5.
15. 1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 1991; 88: 3412-5.
16. Iwasaki S, Tsuruoka N, Hattori A, et al. Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J Biol Chem 1995; 270: 5476-82.
17. Von Hoff DD, Forseth BJ, Huong M, Buchok JB, Lathan B. Improved plating efficiencies for human tumors cloned in capillary tubes versus petri dishes. Cancer Res 1986; 46: 4012-7.
18. Von Hoff DD, Marshall M, Chacon D, et al. Cloning of primary human tumor colony forming units in glass capillaries. J Tissue Culture Methods 1992; 13: 125-31.
19. Hanauske U, Hanauske A, Marshall MH, Muggia VA, Von Hoff DD. Biphasic effect of vanadium salts on in vitro tumor colony growth. Int J Cell Cloning 1987; 5: 170-8.
20. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Ass 1963; 58: 690-700.
21. Koenig BB, Cook JS, Wolsing DH, et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 1994; 14: 5961-74.
22. Liu F, Ventura F, Doody J, Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 1995; 15: 3479-86.
23. Hoodless PA, Haerry T, Abdollah S, et al. MADR1, a MAD-related protein that functions in BMP-2 signaling pathways. Cell 1996; 85: 489-500.
24. Liu F, Hata A, Baker JC, et al. A human MAD protein acting as a BMP-regulated transcriptional activator. Nature 1996; 381: 620-23.
25. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21,1. Science 1996; 271: 351-3.
26. Wakefield LM, Smith DM, Masui T, Haris CC, Sporn MB. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987; 105: 965-75.
27. Yoshikawa H, Rettig WJ, Lane JM, et al. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer 1996; 74: 842-7.
28. Yoshikawa H, Takoaka K, Masuhara K, Ono K, Sakamoto Y. Prognostic significance of bone morphogenetic activity in osteosarcoma tissue. Cancer 1988; 61: 569-73.
29. Harris SE, Harris MA, Mahy P, et al. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 1994; 24: 204-11.